APA (7th ed.) Citation

F, H., YQ, X., XH, W., S, Q., LQ, T., XL, S., . . . RH, X. (2026). Becotatug Vedotin for Recurrent/Metastatic Nasopharyngeal Carcinoma (Magic-M001): A Multicenter, Randomized Trial. Annals of oncology : official journal of the European Society for Medical Oncology. https://doi.org/10.1016/j.annonc.2026.06.003

Chicago Style (17th ed.) Citation

F, Han, et al. "Becotatug Vedotin for Recurrent/Metastatic Nasopharyngeal Carcinoma (Magic-M001): A Multicenter, Randomized Trial." Annals of Oncology : Official Journal of the European Society for Medical Oncology 2026. https://doi.org/10.1016/j.annonc.2026.06.003.

MLA (9th ed.) Citation

F, Han, et al. "Becotatug Vedotin for Recurrent/Metastatic Nasopharyngeal Carcinoma (Magic-M001): A Multicenter, Randomized Trial." Annals of Oncology : Official Journal of the European Society for Medical Oncology, 2026, https://doi.org/10.1016/j.annonc.2026.06.003.